Vivos Therapeutics, Inc. (VVOS) Stock Price, Financial Report, & Fundamental Analysis

Strength

Analysis	#
Revenue Growth VVOS has had growing revenue for the last 5 years
Price to Book (PBV) Ratio Undervalued price-to-book. VVOS stock price is under 1x the price-to-book value.
Debt-Equity Ratio (DER) VVOS equity is higher than it's debt.
Revenue VVOS has positive revenue for last 4 years

Weakness

Analysis	#
Market Cap Small market capitalization. Market capitalization is less than 2bn USD
Net Income Growth VVOS has never had growing net income.
Net Income VVOS never has positive net income for 2 years.
Dividend Yield VVOS has low dividend yield (0%).
Return of Assets VVOS has low return of asset (-207.77%).
Return of Equity VVOS has low return of equity (-215.11%).
Return of Invested Capital VVOS has low ROIC.

Competitors

Financial statements are written records that convey the business activities and the financial performance of a company. Financial statements include the balance sheet, income statement, and statement of cash flow.

Income Statement

Also known as the profit and loss (P&L) statement or the statement of revenue and expense, the income statement primarily focuses on the company’s revenue and expenses during a particular period.

Cashflow Statement

A cash flow statement is a financial statement that provides aggregate data regarding all cash inflows a company receives from its ongoing operations and external investment sources. It also includes all cash outflows that pay for business activities and investments during a given period.

Free Cash Flow

-15,625,000 USD

Dividend

Financial Ratios

CEO

CEO Name

Mr. R. Kirk Huntsman

Management

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Additional Information

Company name

Vivos Therapeutics, Inc.

Symbol

NASDAQ:VVOS

Exchange

NASDAQ Capital Market

Industry

Medical Devices

Sector

Healthcare

Address

9137 South Ridgeline Boulevard
Highlands Ranch
CO
US
80129

Website

https://vivos.com